` TMO (Thermo Fisher Scientific Inc) vs S&P 500 Comparison - Alpha Spread

TMO
vs
S&P 500

Over the past 12 months, TMO has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's 24% growth.

Stocks Performance
TMO vs S&P 500

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
TMO vs S&P 500

Loading
TMO
S&P 500
Difference

Performance By Year
TMO vs S&P 500

Loading
TMO
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Thermo Fisher Scientific Inc vs Peers

S&P 500
TMO
0KHE
DHR
207940
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Thermo Fisher Scientific Inc
Glance View

Economic Moat
Wide
Market Cap
208.4B USD
Industry
Life Sciences Tools & Services

Thermo Fisher Scientific Inc. stands as a towering entity in the life sciences industry, intricately weaving together science, technology, and business to drive scientific progress and innovation. Founded through a merger of Thermo Electron and Fisher Scientific in 2006, the company has grown exponentially to become a formidable partner for researchers, academicians, and clinicians worldwide. Its business model is built around a broad portfolio of offerings, including laboratory instruments, analytical tools, and consumables, which are crucial for research and quality control. By emphasizing research and development, Thermo Fisher has consistently advanced its technologies, ensuring that its solutions remain indispensable to ventures in pharmaceuticals, biotechnology, and diagnostics. The strategic acquisition of complementary businesses has been a key facet of Thermo Fisher’s growth, fortifying its position across various scientific fields. In essence, the company thrives on understanding the increasingly complex demands of the scientific community. It generates revenue by capitalizing on its diverse product lineup, subscription-based services, and personalized solutions that cater to specific client needs—ranging from equipment used to perform intricate genomic sequencing to reagents required for advanced laboratory experiments. Thus, Thermo Fisher sustains its financial health through a combination of one-time sales and recurring revenue streams, a strategy that not only reflects its adaptability but also ensures long-term profitability and market leadership in the ever-evolving landscape of scientific research.

TMO Intrinsic Value
500.74 USD
Overvaluation 8%
Intrinsic Value
Price
Back to Top